Evaluation of Remote Monitoring of Liver Cirrhosis Patients
- Conditions
- Liver Cirrhosis
- Registration Number
- NCT06746246
- Lead Sponsor
- Maastricht University Medical Center
- Brief Summary
The goal of this longitudinal prospective study is to investigate disease course in patients with liver cirrhosis treated in hospitals that implemented a remote monitoring care pathway as part of their standard liver cirrhosis care pathway.
Participants will be asked to share their medical data and remote monitoring data. Therefore, this study does not contain an intervention.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- NOT_YET_RECRUITING
- Sex
- All
- Target Recruitment
- 750
- Liver cirrhosis diagnosis, based on liver biopsy, fibroscan (elastography), radiographic imaging and/or clinical criteria according to applied guidelines at the time of inclusion
- Age 18 years or older
- Treated at Gastroenterology department
- Patients who have declined participation in scientific studies.
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Number of liver related complications From enrollment to the end of follow-up at 15 years, or untill death. Complications defined as: ascites, spontaneous bacterial peritonitis, variceal hemorrhage, hepatorenal syndrome, hepatopulmonary syndrome, hepatocellular carcinoma, liver failure, hepatic encephalopathy.
- Secondary Outcome Measures
Name Time Method Number of liver related clinical admissions From enrollment to the end of follow-up at 15 years, or untill death. Liver related clinical admissions defined as complications related to: ascites, spontaneous bacterial peritonitis, variceal hemorrhage, hepatorenal syndrome, hepatopulmonary syndrome, hepatocellular carcinoma, liver failure, hepatic encephalopathy.
Number of liver related emergency consultations From enrollment to the end of follow-up at 15 years, or untill death. Liver related emergency consultations defined as consultations due to: ascites, spontaneous bacterial peritonitis, variceal hemorrhage, hepatorenal syndrome, hepatopulmonary syndrome, hepatocellular carcinoma, liver failure, hepatic encephalopathy.
Liver transplantation From enrollment to the end of follow-up at 15 years, or untill death. Mortality From enrollment to the end of follow-up at 15 years. Number of outpatient department consultations From enrollment to the end of follow-up at 15 years, or untill death. Physical or telephone
Number of liver related laboratory tests From enrollment to the end of follow-up at 15 years, or untill death. Number of liver related radiographic images From enrollment to the end of follow-up at 15 years, or untill death. Number of liver related biopsies From enrollment to the end of follow-up at 15 years, or untill death. Percentage of completed modules in remote monitoring sessions From enrollment to the end of follow-up at 15 years, or untill death.
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.